Literature DB >> 22079044

Determination of resveratrol and its sulfate and glucuronide metabolites in plasma by LC-MS/MS and their pharmacokinetics in dogs.

Miguel Muzzio1, Zhihua Huang, Shu-Chieh Hu, William D Johnson, David L McCormick, Izet M Kapetanovic.   

Abstract

An analytical approach for the determination of trans-resveratrol (3,5,4'-trihydroxy-trans-stilbene) and its glucuronide and sulfate conjugates in dog plasma by LC-MS/MS (without enzymatic hydrolysis of the conjugates) was validated to support pre-clinical toxicological and pharmacological studies. The approach required two independent sample extractions and consequent instrument runs. Samples for resveratrol determination were prepared by protein precipitation with acetonitrile; acetonitrile-methanol was used instead for resveratrol metabolites. Chromatographic separation was performed using a C18 column (30 mm × 2.0 mm) at a flow rate of 0.25 mL/min. For resveratrol the mobile phase consisted of A: 5mM ammonium acetate in water-isopropanol (98:2, v/v) and B: methanol-isopropanol (98:2, v/v) and for metabolites the mobile phase was modified as follows: A: 0.1% (v/v) formic acid in water and B: 0.1% (v/v) formic acid in acetonitrile. Total run time was 12 min for each run with retention times of about 4-5 min for all analytes. A turbo ion spray source was used operating in negative mode for resveratrol and resveratrol sulfate and in positive mode for resveratrol glucuronide. Calibration curves were linear from 5 to 1000 ng/mL for resveratrol and its glucuronide, and 10-2000 ng/mL for resveratrol sulfate. Linearity was assessed using the internal standard method for resveratrol and the external standard method for the metabolites. Method accuracy was 90-112% of the true value for all analytes with precision of 9% RSD or less for all validation experiments. The validated method was applied to a preclinical toxicology study in dogs after oral administration (200-1200 mg/kg) of the agent. Peak plasma resveratrol concentration (C(max)) for most animals was observed within 1-5 h of dosing, with group mean values in the 1.7-9.9 μg/mL (7.5-43 μM) range. Area under the plasma concentration-time curve (AUC) mean values for resveratrol ranged from 3.6 to 44 h μg/mL for all study groups and were generally proportional to the dose, with no consistent statistically significant changes observed for gender or number of doses. Mean molecular-weight adjusted ratios of resveratrol metabolites to resveratrol for AUC ranged from 1 to 9 for resveratrol glucuronide and from 2 to 11 for resveratrol sulfate.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22079044      PMCID: PMC3235727          DOI: 10.1016/j.jpba.2011.10.023

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  32 in total

1.  Pleiotropic mechanisms facilitated by resveratrol and its metabolites.

Authors:  Barbara Calamini; Kiira Ratia; Michael G Malkowski; Muriel Cuendet; John M Pezzuto; Bernard D Santarsiero; Andrew D Mesecar
Journal:  Biochem J       Date:  2010-07-15       Impact factor: 3.857

2.  Subchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activity.

Authors:  W D Johnson; R L Morrissey; A L Usborne; I Kapetanovic; J A Crowell; M Muzzio; D L McCormick
Journal:  Food Chem Toxicol       Date:  2011-09-10       Impact factor: 6.023

Review 3.  Resveratrol: challenges in translation to the clinic--a critical discussion.

Authors:  Lalita Subramanian; Sherry Youssef; Saswati Bhattacharya; Jason Kenealey; Arthur S Polans; Paul R van Ginkel
Journal:  Clin Cancer Res       Date:  2010-11-02       Impact factor: 12.531

4.  Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats.

Authors:  Izet M Kapetanovic; Miguel Muzzio; Zhihua Huang; Thomas N Thompson; David L McCormick
Journal:  Cancer Chemother Pharmacol       Date:  2010-11-30       Impact factor: 3.333

5.  Pharmacokinetic study of trans-resveratrol in adult pigs.

Authors:  María Azorín-Ortuño; María Josefa Yañéz-Gascón; Francisco J Pallarés; Fernando Vallejo; Mar Larrosa; María Teresa García-Conesa; Francisco Tomás-Barberán; Juan Carlos Espín
Journal:  J Agric Food Chem       Date:  2010-10-01       Impact factor: 5.279

6.  Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients.

Authors:  Ketan R Patel; Victoria A Brown; Donald J L Jones; Robert G Britton; David Hemingway; Andrew S Miller; Kevin P West; Tristan D Booth; Marjorie Perloff; James A Crowell; Dean E Brenner; William P Steward; Andreas J Gescher; Karen Brown
Journal:  Cancer Res       Date:  2010-09-14       Impact factor: 12.701

7.  Inhibition of cancer growth by resveratrol is related to its low bioavailability.

Authors:  Miguel Asensi; Ignacio Medina; Angel Ortega; Julian Carretero; M Carmen Baño; Elena Obrador; Jose M Estrela
Journal:  Free Radic Biol Med       Date:  2002-08-01       Impact factor: 7.376

Review 8.  Resveratrol bioavailability and toxicity in humans.

Authors:  Charles-Henry Cottart; Valérie Nivet-Antoine; Christelle Laguillier-Morizot; Jean-Louis Beaudeux
Journal:  Mol Nutr Food Res       Date:  2010-01       Impact factor: 5.914

9.  Human, rat, and mouse metabolism of resveratrol.

Authors:  Chongwoo Yu; Young Geun Shin; Anita Chow; Yongmei Li; Jerome W Kosmeder; Yong Sup Lee; Wendy H Hirschelman; John M Pezzuto; Rajendra G Mehta; Richard B van Breemen
Journal:  Pharm Res       Date:  2002-12       Impact factor: 4.200

10.  Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model.

Authors:  Jean-Francois Marier; Pascal Vachon; Ari Gritsas; Jie Zhang; Jean-Pierre Moreau; Murray P Ducharme
Journal:  J Pharmacol Exp Ther       Date:  2002-07       Impact factor: 4.030

View more
  18 in total

Review 1.  Glucuronidated Flavonoids in Neurological Protection: Structural Analysis and Approaches for Chemical and Biological Synthesis.

Authors:  Maite Docampo; Adiji Olubu; Xiaoqiang Wang; Giulio Pasinetti; Richard A Dixon
Journal:  J Agric Food Chem       Date:  2017-08-21       Impact factor: 5.279

2.  Resveratrol preserves the function of human platelets stored for transfusion.

Authors:  Katie L Lannan; Majed A Refaai; Sara K Ture; Craig N Morrell; Neil Blumberg; Richard P Phipps; Sherry L Spinelli
Journal:  Br J Haematol       Date:  2015-12-18       Impact factor: 6.998

3.  Improvement of Resveratrol Effects When Combined with Rice Oil in Rat Models of Inflammation.

Authors:  Rodrigo B M Silva; Izaque S Maciel; Alice Ribeiro; Gabriel Rübensam; Andressa Bernardi; Fernanda B Morrone; Andre A Souto; Maria M Campos
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

Review 4.  Roles of plant-based ingredients and phytonutrients in canine nutrition and health.

Authors:  Jirayu Tanprasertsuk; Devon E Tate; Justin Shmalberg
Journal:  J Anim Physiol Anim Nutr (Berl)       Date:  2021-09-08       Impact factor: 2.718

5.  Bioavailability and safety study of resveratrol 500 mg tablets in healthy male and female volunteers.

Authors:  Christakis Sergides; Marinela Chirilă; Luigi Silvestro; Daphne Pitta; Andreas Pittas
Journal:  Exp Ther Med       Date:  2015-11-25       Impact factor: 2.447

6.  3,3'-Diindolylmethane Exhibits Significant Metabolism after Oral Dosing in Humans.

Authors:  Monica L Vermillion Maier; Lisbeth K Siddens; Sandra L Uesugi; Jaewoo Choi; Scott W Leonard; Jamie M Pennington; Susan C Tilton; Jordan N Smith; Emily Ho; H H Sherry Chow; Bach D Nguyen; Siva K Kolluri; David E Williams
Journal:  Drug Metab Dispos       Date:  2021-05-25       Impact factor: 3.579

7.  Stabilization of resveratrol in blood circulation by conjugation to mPEG and mPEG-PLA polymers: investigation of conjugate linker and polymer composition on stability, metabolism, antioxidant activity and pharmacokinetic profile.

Authors:  Basavaraj Siddalingappa; Heather A E Benson; David H Brown; Kevin T Batty; Yan Chen
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

8.  Resveratrol metabolism in a non-human primate, the grey mouse lemur (Microcebus murinus), using ultra-high-performance liquid chromatography-quadrupole time of flight.

Authors:  Marie-Claude Menet; Julia Marchal; Alexandre Dal-Pan; Méryam Taghi; Valérie Nivet-Antoine; Delphine Dargère; Olivier Laprévote; Jean-Louis Beaudeux; Fabienne Aujard; Jacques Epelbaum; Charles-Henry Cottart
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

9.  Evidence supporting the conceptual framework of cancer chemoprevention in canines.

Authors:  Tamara P Kondratyuk; Julie Ann Luiz Adrian; Brian Wright; Eun-Jung Park; Richard B van Breemen; Kenneth R Morris; John M Pezzuto
Journal:  Sci Rep       Date:  2016-05-24       Impact factor: 4.379

10.  Resveratrol analogue 4,4'-dihydroxy-trans-stilbene potently inhibits cancer invasion and metastasis.

Authors:  Monica Savio; Daniela Ferraro; Cristina Maccario; Rita Vaccarone; Lasse D Jensen; Federica Corana; Barbara Mannucci; Livia Bianchi; Yihai Cao; Lucia Anna Stivala
Journal:  Sci Rep       Date:  2016-02-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.